Sutro Biopharma Profit Margin 2017-2021 | STRO
Current and historical gross margin, operating margin and net profit margin for Sutro Biopharma (STRO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Sutro Biopharma net profit margin as of September 30, 2021 is -213.36%.
|Sutro Biopharma Annual Profit Margins
|Sutro Biopharma Quarterly Profit Margins
||Medical - Biomedical and Genetics
Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.